A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomy.

BJU Int · 2025 · PMC11913596 · PMID 39485082

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significanceP = 0.06so close (0.05 < p ≤ 0.1)

Fine‐Gray competing risks regression showed significantly lower rates of CSM in patients with the luminal favourable subtype on UVA (sHR 0.32, 95% CI 0.12–0.87; P = 0.03), with similar results on MVA that did not reach statistical significance (sHR 0.38, 95% CI 0.14–1.05; P = 0.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.